These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 12713553)

  • 21. Efficacy and safety of topical tacrolimus for the treatment of face and neck vitiligo.
    Lo YH; Cheng GS; Huang CC; Chang WY; Wu CS
    J Dermatol; 2010 Feb; 37(2):125-9. PubMed ID: 20175845
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Vitiligo. Treatment of 12 cases with topical tacrolimus].
    Almeida P; Borrego L; Rodríguez-López J; Luján D; Cameselle D; Hernández B
    Actas Dermosifiliogr; 2005 Apr; 96(3):159-63. PubMed ID: 16476357
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Granuloma faciale: a good therapeutic response with the use of topical tacrolimus.
    Lima RS; Maquiné GÁ; Silva Junior RC; Schettini AP; Santos M
    An Bras Dermatol; 2015; 90(5):735-7. PubMed ID: 26560220
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effects of tacrolimus plus phototherapy in the treatment of vitiligo: a meta-analysis.
    Dong Y; Yang Q; Guo B; Zhu J; Sun X
    Arch Dermatol Res; 2021 Aug; 313(6):461-471. PubMed ID: 32785837
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Accelerated repigmentation of vitiligo after an irritant reaction following occlusion dressing with topical tacrolimus.
    Ju HJ; Lee JH; Kim GM; Park CJ; Bae JM
    Eur J Dermatol; 2018 Jun; 28(3):388-390. PubMed ID: 29619991
    [No Abstract]   [Full Text] [Related]  

  • 26. Topical tacrolimus is more effective for treatment of vitiligo in patients of skin of color.
    Silverberg JI; Silverberg NB
    J Drugs Dermatol; 2011 May; 10(5):507-10. PubMed ID: 21533297
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Topical tacrolimus and the 308-nm excimer laser: a synergistic combination for the treatment of vitiligo.
    Passeron T; Ostovari N; Zakaria W; Fontas E; Larrouy JC; Lacour JP; Ortonne JP
    Arch Dermatol; 2004 Sep; 140(9):1065-9. PubMed ID: 15381545
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Focal acne during topical tacrolimus therapy for vitiligo.
    Bakos L; Bakos RM
    Arch Dermatol; 2007 Sep; 143(9):1223-4. PubMed ID: 17875902
    [No Abstract]   [Full Text] [Related]  

  • 29. A pilot comparative study of topical latanoprost and tacrolimus in combination with narrow-band ultraviolet B phototherapy and microneedling for the treatment of nonsegmental vitiligo.
    Korobko IV; Lomonosov KM
    Dermatol Ther; 2016 Nov; 29(6):437-441. PubMed ID: 27329330
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Multifocal facial eosinophilic granuloma: successful treatment with topical tacrolimus].
    Rieker J; Hengge U; Ruzicka T; Bruch-Gerharz D
    Hautarzt; 2006 Apr; 57(4):324-6. PubMed ID: 16523273
    [No Abstract]   [Full Text] [Related]  

  • 31. Topical tacrolimus for treatment of childhood vitiligo in Asians.
    Kanwar AJ; Dogra S; Parsad D
    Clin Exp Dermatol; 2004 Nov; 29(6):589-92. PubMed ID: 15550128
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A double-blind, randomized, placebo-controlled trial of topical tacrolimus 0·1% vs. clobetasol propionate 0·05% in childhood vitiligo.
    Ho N; Pope E; Weinstein M; Greenberg S; Webster C; Krafchik BR
    Br J Dermatol; 2011 Sep; 165(3):626-32. PubMed ID: 21457214
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Focal hypertrichosis during topical tacrolimus therapy for childhood vitiligo.
    Prats Caelles I; Herranz Pinto P; de Ayala Casado EL; de Lucas Laguna R
    Pediatr Dermatol; 2005; 22(1):86-7. PubMed ID: 15660910
    [No Abstract]   [Full Text] [Related]  

  • 34. Successful treatment of vitiligo with 0.1% tacrolimus ointment.
    Travis LB; Weinberg JM; Silverberg NB
    Arch Dermatol; 2003 May; 139(5):571-4; discussion 573. PubMed ID: 12756092
    [No Abstract]   [Full Text] [Related]  

  • 35. The successful use of topical tacrolimus treatment for a chronic actinic dermatitis patient with complications of idiopathic leukopenia.
    Ogawa Y; Adachi A; Tomita Y
    J Dermatol; 2003 Nov; 30(11):805-9. PubMed ID: 14684938
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tacrolimus-induced hyperpigmentation in a patch of vitiligo.
    De D; Kanwar AJ
    Skinmed; 2008; 7(2):93-4. PubMed ID: 18327009
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Narrow-band UVB phototherapy combined with tacrolimus ointment in vitiligo: a review of 110 patients.
    Fai D; Cassano N; Vena GA
    J Eur Acad Dermatol Venereol; 2007 Aug; 21(7):916-20. PubMed ID: 17659000
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Facial lichen striatus: successful treatment with tacrolimus ointment.
    Fujimoto N; Tajima S; Ishibashi A
    Br J Dermatol; 2003 Mar; 148(3):587-90. PubMed ID: 12653755
    [TBL] [Abstract][Full Text] [Related]  

  • 39. sQuiz your knowledge: Asymptomatic plaques on the face.
    Bouceiro-Mendes R; Roda Â; Soares-De-Almeida L
    Eur J Dermatol; 2020 Apr; 30(2):214-215. PubMed ID: 32538367
    [No Abstract]   [Full Text] [Related]  

  • 40. Targeted and combination treatments for vitiligo. Comparative evaluation of different current modalities in 458 subjects.
    Lotti T; Buggiani G; Troiano M; Assad GB; Delescluse J; De Giorgi V; Hercogova J
    Dermatol Ther; 2008 Jul; 21 Suppl 1():S20-6. PubMed ID: 18727812
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.